echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JAMA Dermatol: Comparison of the efficacy of systemic immunomodulatory therapy for atopic dermatitis

    JAMA Dermatol: Comparison of the efficacy of systemic immunomodulatory therapy for atopic dermatitis

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Systemic immunomodulators used to treat atopic dermatitis include cyclosporine, methotrexate, azathioprine, mycophenolate mofetil, and dupilumab, abrutinib, braziltinib, tralotinib Kinumab and upadacitinib were recently approved in different countries
    .


    There are few face-to-face trials of these drugs, making direct comparisons of efficacy and safety difficult


    Since October 2019, 21 new studies have been added for a total of 60 trials with a total of 16 579 patients
    .


    Adults treated for up to 16 weeks, abrocitinib, 200 mg daily (mean difference [MD], 2.


    Our study found that acrotinib 200 mg daily and upadacitinib 30 mg daily may have slightly higher index scores than dupilumab 600 mg and 300 mg biweekly
    .


    Our results may help clinicians understand the differences between different treatment options for moderate-to-severe atopic dermatitis


    Source: Drucker AM, Morra DE, Prieto-Merino D, Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.